Solara Active Pharma Sciences Ltd
Company Profile
Business description
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
Contact
Phase II - CSIR Road
Module No. 601, 602, 603, Ticel Bio Park
Taramani
ChennaiTN600113
INDT: +91 4447406200
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
2,924
Stocks News & Analysis
stocks
Anglo American strikes deal to create a new copper giant
stocks
The ‘other’ AI chip behemoth that might just be getting started
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,071.40 | 9.10 | -0.10% |
CAC 40 | 7,835.31 | 73.99 | 0.95% |
DAX 40 | 23,744.73 | 111.78 | 0.47% |
Dow JONES (US) | 45,935.55 | 444.63 | 0.98% |
FTSE 100 | 9,284.08 | 58.69 | 0.64% |
HKSE | 26,086.32 | 113.94 | -0.43% |
NASDAQ | 21,984.57 | 98.51 | 0.45% |
Nikkei 225 | 44,372.50 | 534.83 | 1.22% |
NZX 50 Index | 13,229.15 | 47.09 | -0.35% |
S&P 500 | 6,568.09 | 36.05 | 0.55% |
S&P/ASX 200 | 8,805.00 | 8.80 | -0.10% |
SSE Composite Index | 3,875.31 | 63.09 | 1.65% |